NANOMEDICINE: will it offer possibilities to overcome multiple drug resistance in cancer?

S Friberg, AM Nyström - Journal of Nanobiotechnology, 2016 - Springer
This review is written with the purpose to review the current nanomedicine literature and
provide an outlook on the developments in utilizing nanoscale drug constructs in treatment …

Efficient EFGR mediated siRNA delivery to breast cancer cells by Cetuximab functionalized Pluronic® F127/Gelatin

D Rafael, F Martínez, F Andrade… - Chemical Engineering …, 2018 - Elsevier
New polymeric biomaterials and nanomedicines targeting cancer cells are highly required
because of their potential clinical applications. Gene therapy enjoys high popularity as …

Targeted siRNA delivery reduces nitric oxide mediated cell death after spinal cord injury

W Gao, J Li - Journal of nanobiotechnology, 2017 - Springer
Background Traumatic spinal cord injury (SCI) includes the primary insult as well as a
sequela of biochemical and cellular cascades that amplifies the initial injury. This …

Current non-viral siRNA delivery systems as a promising treatment of skin diseases

J Rosa, I Suzuki, M Kravicz, A Caron… - Current …, 2018 - ingentaconnect.com
Background: Gene therapy is a new approach to discover and treat many diseases. It has
attracted considerable attention from researchers in the last decades. The gene therapy …

Periostin in intrahepatic cholangiocarcinoma: pathobiological insights and clinical implications

AE Sirica, JA Almenara, C Li - Experimental and molecular pathology, 2014 - Elsevier
Periostin is a modular glycoprotein frequently observed to be a major constituent of the
extracellular milieu of mass-forming intrahepatic cholangiocarcinoma and other …

Calcium–siRNA nanocomplexes: What reversibility is all about

E Ruvinov, O Kryukov, E Forti, E Korin… - Journal of controlled …, 2015 - Elsevier
Gene silencing using small interfering RNA (siRNA) relies on the critical need for a safe and
effective carrier, capable of strong but reversible complexation, siRNA protection, cellular …

Delivery of RNAi-based therapeutics for bone regeneration

DW Malcolm, Y Wang, C Overby, M Newman… - Current osteoporosis …, 2020 - Springer
Abstract Purpose of Review The clinical significance, target pathways, recent successes,
and challenges that preclude translation of RNAi bone regenerative approaches are …

HER2 siRNA Facilitated Gene Silencing Coupled with Doxorubicin Delivery: A Dual Responsive Nanoplatform Abrogates Breast Cancer

A MG, A KS, U BS, R PL, S HP… - ACS Applied Materials …, 2024 - ACS Publications
The present study investigated the concurrent delivery of antineoplastic drug, doxorubicin,
and HER2 siRNA through a targeted theranostic metallic gold nanoparticle designed using …

[HTML][HTML] Boosting therapeutic efficacy of mesenchymal stem cells in pulmonary fibrosis: The role of genetic modification and preconditioning strategies

M Mehrabani, S Mohammadyar… - Iranian Journal of …, 2023 - ncbi.nlm.nih.gov
Pulmonary fibrosis (PF) is the end stage of severe lung diseases, in which the lung
parenchyma is replaced by fibrous scar tissue. The result is a remarkable reduction in …

Cetuximab–siRNA conjugate linked through cationized gelatin knocks down KRAS G12C mutation in NSCLC sensitizing the cells toward gefitinib

K Sreedurgalakshmi, R Srikar… - … in Cancer Research …, 2021 - journals.sagepub.com
Delivery of small-interfering RNA (siRNA) has been of great interest in the past decade for
effective gene silencing. To overcome synthetic and regulatory challenges posed by …